Jill Biden’s visit to Hollings brings awareness to mammograms missed during the pandemic

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

In mid-October, First Lady Dr. Jill Biden asked to visit the Hollings Cancer Center at the Medical University of South Carolina to help raise awareness of the need for breast cancer screening, education, and treatment—particularly among underserved minority women. 

She expressed concern that the number of routine mammograms had dropped dramatically during the COVID pandemic, particularly among this often-neglected cohort. 

We are all concerned that while fewer Black and minority women in South Carolina are diagnosed with breast cancer, a larger number of them die of the disease. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Raymond N. DuBois, MD, PhD
Director, Hollings Cancer Center and Dean of Medicine, The Medical University of South Carolina
Table of Contents

YOU MAY BE INTERESTED IN

Genentech announced positive topline results from the overall survival analysis of the phase III INAVO120 study investigating Itovebi (inavolisib) in combination with palbociclib (Ibrance) and fulvestrant for people with PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor 2-negative, endocrine-resistant, locally advanced or metastatic breast cancer. 
FDA approved AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-low (IHC 1+ or IHC 2+/ISH-) or HER2-ultralow (IHC 0 with membrane staining) breast cancer, as determined by the FDA approved test, that has progressed on one or more endocrine therapies in the metastatic setting.
Raymond N. DuBois, MD, PhD
Director, Hollings Cancer Center and Dean of Medicine, The Medical University of South Carolina

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login